Your browser doesn't support javascript.
loading
Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Kong, Lin; Gao, Jing; Hu, Jiyi; Hu, Weixu; Guan, Xiyin; Lu, Rong; Lu, Jiade J.
Afiliação
  • Kong L; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Shanghai Cancer Hospital, Shanghai, 200321, P. R. China.
  • Gao J; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, 200321, P. R. China.
  • Hu J; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, 200321, P. R. China.
  • Hu W; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, 200321, P. R. China.
  • Guan X; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, 200321, P. R. China.
  • Lu R; Department of Outpatient Clinic, Shanghai Proton and Heavy Ion Center, Shanghai, 200321, P. R. China.
  • Lu JJ; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, 200321, P. R. China. jiade.lu@sphic.org.cn.
Chin J Cancer ; 35(1): 101, 2016 12 22.
Article em En | MEDLINE | ID: mdl-28007028

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Cisplatino / Terapia de Salvação / Quimiorradioterapia / Radioterapia com Íons Pesados / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Cisplatino / Terapia de Salvação / Quimiorradioterapia / Radioterapia com Íons Pesados / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article